How Much Did Coremap Raise?
Funding & Key Investors

Coremap, a company specializing in advanced technology for the diagnosis and treatment of atrial fibrillation (AF), has secured significant enterprise-level funding, with a recent major strategic investment of $23M contributing to a total funding amount of $33.5M. This capital infusion underscores the growing investor confidence in the company's innovative solutions for visualizing and treating irregular heartbeats.

What is Coremap?

Coremap
ManufacturingMedical Devices & Equipment

CoreMap is at the forefront of medical technology, developing advanced solutions for the diagnosis and treatment of atrial fibrillation (AF). Their innovative platforms empower physicians with enhanced visualization capabilities for AF, aiming to significantly improve patient treatment outcomes. The company's commitment to research and development in cardiovascular health is supported by a distinguished team of medical and biomedical engineering experts.

How much funding has Coremap raised?

Coremap has raised a total of $69M across 2 funding rounds:

2020

Series A

$10.5M

2022

Series B

$23M

Series A (2020): $10.5M with participation from Ronny Ginor and Qure Ventures

Series B (2022): $23M led by Russ Scully and Qure Ventures

Key Investors in Coremap

Qure Ventures

Qure Ventures is Israel's first exclusively focused digital health fund, investing in startups within the country's leading tech and digital health ecosystem. The company aims to revolutionize medicine through digital health solutions, addressing the growing healthcare demands of an aging global population. With strategic partnerships across consumer, provider, payer, and pharma domains, Qure provides its portfolio companies with fast track access to market and clinical trial opportunities. Led by experienced digital health veterans, Qure Ventures is committed to making a significant impact on health and wellbeing for current and future generations.

Russ Scully

An individual investor participating in Coremap's Series B funding round.

Ronny Ginor

An individual investor participating in Coremap's Series A funding round.

What's next for Coremap?

With the recent influx of capital, Coremap is poised for accelerated growth and further innovation in the AF treatment landscape. This strategic investment will likely fuel the expansion of their technological development, clinical validation, and market penetration efforts. The company's focus on improving diagnostic accuracy and treatment efficacy positions it for a significant impact on patient care and the broader digital health sector.

See full Coremap company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingPlastic, Packaging & ContainersLaw Firms & Legal Services
ManufacturingWatches & Jewelry
Food & BeverageManufacturing
Building MaterialsManufacturing

Frequently Asked Questions Regarding Coremap Financial Insights

What are the most recent funding rounds that Coremap has completed, and what were the funding rounds?
Coremap has recently completed 2 funding rounds: Series B on Feb 9, 2022, Series A on Sep 16, 2020.
What is the total amount of funding Coremap has raised to date?
Coremap has raised a total of $69M in funding to date.
How many funding rounds has Coremap completed?
Coremap has completed 2 funding rounds.
How much funding did Coremap raise in its most recent funding round?
Coremap raised $23M in its most recent funding round.
Who are the lead investors in Coremap's latest funding round?
The lead investor in Coremap's latest funding round was Russ Scully. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Coremap's history?
The largest funding round in Coremap's history was $23M.
See more information about Coremap